A 38-year-old woman from rural Rajasthan presents with a 3-month history of progressive fatigue, dyspnea on exertion, and menorrhagia. On examination, she appears pale with a systolic flow murmur. Laboratory investigations show: Hemoglobin 7.2 g/dL, MCV 62 fL, MCH 18 pg, serum iron 35 µg/dL (normal 60–170), ferritin 8 ng/mL (normal 12–150), TIBC 420 µg/dL (normal 250–425), and reticulocyte count 1.2%. Peripheral blood smear shows microcytic hypochromic RBCs with occasional target cells. What is the next most appropriate step in the management of her anemia?

Explanation

## Clinical Diagnosis This patient has **iron deficiency anemia (IDA)** with clear evidence of iron depletion: - Microcytic hypochromic indices (MCV 62, MCH 18) - Low serum iron, low ferritin, elevated TIBC (classic iron depletion pattern) - Menorrhagia as the likely source in a reproductive-age woman - Reticulocyte count appropriately low (bone marrow response inadequate due to iron lack) ## Management Algorithm ```mermaid flowchart TD A["Iron Deficiency Anemia Confirmed"]:::outcome --> B{"Identify Source"}:::decision B -->|"Premenopausal woman"|C["Menorrhagia likely"]:::action B -->|"Postmenopausal/Male"|D["GI bleeding likely"]:::action C --> E["Start oral iron + gynecology referral"]:::action D --> F["Perform GI endoscopy"]:::action E --> G["Reassess Hb in 4-6 weeks"]:::action G --> H{"Response adequate?"}:::decision H -->|"Yes"|I["Continue iron, investigate menorrhagia"]:::action H -->|"No"|J["Consider GI source, IV iron, or malabsorption"]:::urgent ``` ## Why Oral Iron First? **Key Point:** In a premenopausal woman with IDA and menorrhagia as the obvious source, **empirical oral iron therapy is the standard first-line approach** — not bone marrow biopsy or endoscopy. **High-Yield:** The reticulocyte count will rise to 3–5% within 3–5 days of starting iron if the diagnosis is correct and absorption is adequate. Hemoglobin should increase by 1–2 g/dL per month. **Clinical Pearl:** Menorrhagia accounts for >80% of IDA in premenopausal women in resource-limited settings. Gynecology referral for menorrhagia management (hormonal contraception, tranexamic acid, or surgical intervention) is essential to prevent recurrence. ## When to Escalate - **No response after 4–6 weeks** → suspect malabsorption, non-adherence, or ongoing blood loss exceeding replacement - **Postmenopausal or male patient** → GI endoscopy is mandatory (IDA is GI bleeding until proven otherwise) - **Hemoglobin <5 g/dL with symptoms** → transfusion may be needed, but iron therapy still continues [cite:Harrison 21e Ch 97]